רופילק 300

देश: इसराइल

भाषा: हिब्रू

स्रोत: Ministry of Health

सक्रिय संघटक:

ANTI-D IMMUNOGLOBULINS

थमां उपलब्ध:

CSL BEHRING LTD., ISRAEL

ए.टी.सी कोड:

J06BB01

फार्मास्यूटिकल फॉर्म:

תמיסה להזרקה

रचना:

ANTI-D IMMUNOGLOBULINS 150 MCG/ML

प्रशासन का मार्ग:

תוך-שרירי, תוך-ורידי

प्रिस्क्रिप्शन प्रकार:

מרשם נדרש

द्वारा बनाया गया:

CSL BEHRING AG, SWITZERLAND

चिकित्सीय समूह:

ANTI-D (RH) IMMUNOGLOBULIN

चिकित्सीय क्षेत्र:

ANTI-D (RH) IMMUNOGLOBULIN

चिकित्सीय संकेत:

Prophylaxis of Rh (D) immunisation in Rh (D)-negative women: Anti-D immune globulin is administered for the prevention of Rh (D) immunization if it has been demonstrated or if it is suspected that fetal erythrocytes have entered the circulation of the mother. Treatment is not necessary when it is assured that the child or the father are Rh (D)- negative. Criteria for a rhesus-incompatible pregnancy and the administration of anti-D immune globulin are : a) the mother is Rh (D) -negative b) the child is either Rh (D)-positive Rh (D)weak - positive or its rhesus type is not known. Routine antepartum prophylaxis : To prevent Rh (D) immunisation due to spontaneous fetomaternal haemorrhage (FMH) during the last trimester of pregnancy. Postpartum prophylaxis To prevent Rh (D) immunisation of the Rh (D)-negative mother following delivery of a Rh (D)-positive child. Complications of pregnancy: Interventions during pregnancy such as invasive prenatal diagnosis (e.g. amniocentesis chorionic villus sampling fetal blood s

प्राधिकरण की तारीख:

2023-02-28